Navigation Links
Hysterectomy increases risk for earlier menopause among younger women
Date:11/14/2011

DURHAM, N.C. In a finding that confirms what many obstetricians and gynecologists suspected, Duke University researchers report that younger women who undergo hysterectomies face a nearly two-fold increased risk for developing menopause early.

The study, published in the December issue of the journal Obstetrics & Gynecology, is the largest analysis to track over time the actual hormonal impact of woman who had hysterectomies and compare them to women whose uteruses remained intact.

"Hysterectomy is a common treatment for many conditions, including fibroids and excessive bleeding," said Patricia G. Moorman, PhD., MSPH, an associate professor in the Department of Community and Family Medicine at Duke University and lead author of the study. "Most women are very satisfied with the results of a hysterectomy. But this is a potential risk of the surgery that should be considered along with the benefit."

Up to 600,000 women in the United States undergo hysterectomy each year, but the long-term consequences of the procedure have not been well documented. Studies have been small, or relied on the recollections of women about the onset of menopause.

The Duke team enrolled nearly 900 women ages 30 to 47 at two hospitals in Durham, N.C. -- Duke University Medical Center and Durham Regional Hospital and followed up with blood tests and questionnaires for five years. Half the women, 465, were healthy controls who had no surgery, while 406 women underwent hysterectomies that spared at least one ovary.

Preserving the ovaries while removing the uterus is a strategy designed to allow a woman's hormone production to continue, which has health benefits. Moorman said doctors have long known that early menopause either from surgery or from other factors that halt egg production can increase a woman's risk of osteoporosis, heart disease and other ailments.

Yet despite preserving the ovaries, the Duke team found that 14.8 percent of women in the study who had hysterectomies experienced menopause over the course of the study, compared to 8 percent of women who had no surgery. The risk for menopause was highest among women who had one ovary removed along with their uterus, but it remained elevated even when both ovaries stayed in place. The Duke team's analysis estimated that menopause occurred approximately two years earlier in the women who underwent hysterectomy.

Moorman said it's unknown what triggers the ovaries of some women to shut down after a hysterectomy.

"Some have hypothesized that surgery disrupts the blood flow to the ovaries, so the surgery leads to early ovarian failure," she said. "Others have speculated it's not the surgery, but the underlying condition preceding the surgery that causes it. Right now, it's unresolved."

Regardless of the cause, Moorman said the Duke finding provides women and their doctors with concrete information about a potential risk.

"This could potentially change practice because women who are considering hysterectomy for fibroids or other problems may want to explore other treatment options for their condition if they know they may go through menopause earlier," Moorman said.


'/>"/>

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center
Source:Eurekalert

Related biology news :

1. Avoiding hysterectomy: Major interventional radiology E-collection info available
2. Exercise increases brain growth factor and receptors, prevents stem cell drop in middle age
3. European ancestry increases breast cancer risk among Latinas
4. Long-term use of diabetes drugs by women significantly increases risk of fractures
5. Sweetened beverage consumption increases in the US
6. Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants
7. Indoor air pollution increases asthma symptoms
8. Lower increases in global temps could lead to greater impacts than previously thought, study finds
9. Agent Orange exposure increases veterans risk of aggressive recurrence of prostate cancer
10. Researchers identify a molecule that increases the risk of cardiac insufficiency
11. The battle for CRTC2: How obesity increases the risk for diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
Breaking Biology Technology: